In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...

Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at preventing infection, data show.

Bianna speaks to Dr. Hussein Tawbi, oncologist and researcher at the University of Texas MD Anderson Cancer Center who leads the Phase 3 melanoma vaccine trial, and Dr. Ezekiel Emanuel, former Obama ...

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big ...

Share on Pinterest Moderna’s new mRNA flu vaccine has been approved by the FDA for adults ages 50 years and older. FatCamera, E+/Getty Images The Food and Drug Administration (FDA) has approved ...

The central dogma of biology defines the flow of genetic information: It describes how proteins are made from mRNA templates, which are in turn made from DNA. Exporting the mRNA from inside the ...

The new mRNA vaccine provides more protection than the standard flu shot.

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and throat from respiratory viruses has been identified. The discovery, led by ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial. However, the speed of vaccine production is ...

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

While mRNA may be back in the headlines courtesy of Moderna and Merck & Co.'s phase 3 cancer vaccine success, new research ...